Popular epilepsy drug recalled nationwide: Here's why

A popular prescription medicine used nationwide for epilepsy and bipolar disorder, Depakote, is being recalled, according to a Food and Drug Administration enforcement report. The recall concerns divalproex sodium delayed-release tablets, which are available in 500-mg strengths and sold in 500-tablet bottles by prescription. The distributor, Bionpharma Inc., initiated the voluntary recall after foreign tablets and capsules were reported. The enforcement report indicates a packaging and manufacturing error that could result in cross-contamination between pills or capsules. The report states the recall, begun in late June, has not yet been classified. WPIX in New York said it reached out to the company for comment, but it was not immediately available. The article focuses on the administrative details and reported cause of the recall rather than patient outcomes.